Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

3rd Quarter Results

9 Dec 2020 07:00

RNS Number : 9949H
Marble Point Loan Financing Limited
09 December 2020
 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IT IS NOT AN OFFER TO PURCHASE, OR A SOLICITATION OF AN OFFER TO SELL, ANY NOTES OR OTHER SECURITIES.

 

 

 

9 December 2020

 

 

 

Marble Point Loan Financing Limited

(the "Company")

 

Publication of Q3 2020 Unaudited Consolidated Financial Statements

 

 

The Board of Directors of the Company is pleased to release the Company's Q3 2020 Unaudited Consolidated Financial Statements for the period ending 30 September 2020.

 

In addition, the Company has made available certain additional information for noteholders of the 7.50% Senior Notes Due 16 November 2025. This information together with the Q3 2020 Unaudited Consolidated Financial Statements is available on the Company's website.

 

Click on, or paste the following link into your web browser, to view the Q3 2020 Unaudited Consolidated Financial Statements.

 

http://www.rns-pdf.londonstockexchange.com/rns/9949H_1-2020-12-8.pdf

The Q3 Unaudited Consolidated Financial Statements will also be available on the Company's website at:

 

 www.mplflimited.com 

 

 

Enquiries:

 

Marble Point Loan Financing Limited

Investor Relations

Tel.: +44 (0) 20 7259 1500

Email: ir@mplflimited.com

 

Corporate Broker

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

 

Financial Public Relations

Charlie Barker / Catherine Chapman

MHP Communications

P: +44 (0) 20 3128 8100

MarblePoint@mhpc.com

 

Past performance is not indicative or a guarantee of future performance.

ABOUT MARBLE POINT LOAN FINANCING LIMITED

About Marble Point Loan Financing

Marble Point Loan Financing Ltd. (LSE Ticker: MPLF LN (USD); MPLS LN (GBX)) is a Guernsey-domiciled closed-ended investment company. MPLF's investment objective is to generate stable current income and grow net asset value by earning a return on equity in excess of the amount distributed as dividends.

MPLF is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans owned via collateralised loan obligations ("CLOs") and related vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission.

 

About Marble Point Credit Management LLC

Marble Point Credit Management LLC ("Marble Point") is a specialist asset manager focused exclusively on leveraged loans. Marble Point was founded by Thomas Shandell in partnership with Eagle Point Credit Management, a leading investor in CLO securities.

IMPORTANT INFORMATION

Marble Point Loan Financing Limited (the "Company") is a closed-ended investment company incorporated in Guernsey with its ordinary shares ("Shares") admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (ticker: MPLF.LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission.

This document is for information purposes only and has been issued by, and is the sole responsibility of, the Company. This document and the information and views included herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Company or any of its affiliates. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of any investment and should consult its own legal counsel and financial, actuarial, accounting, regulatory and tax advisers to evaluate any such investment. This document is provided for informational purposes only, does not constitute an offer to sell shares issued by the Company (the "Shares") or a solicitation of an offer to purchase any such Shares in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction, and is not a prospectus. This document may not be relied upon and should not be used for the purpose of making any investment decision.

 

The Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act.

 

Past performance is not a reliable indicator of current of future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

 

No recipient may forward, reproduce, distribute, or make available in whole or in part, this document (directly or indirectly) to any other person. The distribution of this document in certain jurisdictions may be restricted by law and recipients of this document should inform themselves about and observe any such restrictions and other applicable legal requirements in their jurisdictions. This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Australia, Canada, the Republic of South Africa or Japan or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa or Japan. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States or the laws of other jurisdictions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTUPGUWPUPUPWR
Date   Source Headline
23rd May 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd May 20227:00 amRNS1st Quarter Results
22nd Apr 20224:36 pmRNSDividend Declaration
21st Apr 20227:00 amRNSNet Asset Value & Publication of Monthly Report
8th Apr 20225:09 pmRNSAnnual Financial Report
31st Mar 20226:00 pmRNSDividend Declaration
24th Mar 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Feb 20227:00 amRNSNet Asset Value & Publication of Monthly Report
31st Jan 20223:25 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSNet Asset Value & Publication of Monthly Report
20th Jan 20225:33 pmRNSDividend Declaration
4th Jan 20227:00 amRNSDirector/PDMR Shareholding
29th Dec 20217:00 amRNSDividend Declaration
23rd Dec 20217:00 amRNSNet Asset Value & Publication of Monthly Report
24th Nov 20217:00 amRNS3rd Quarter Results
23rd Nov 20217:00 amRNSNet Asset Value & Publication of Monthly Report
19th Nov 20213:23 pmRNSResult of AGM
9th Nov 20215:21 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSNotice of AGM
3rd Nov 20214:25 pmRNSTransaction in Own Shares
27th Oct 20217:00 amRNSTransaction in Own Shares
21st Oct 20215:21 pmRNSDividend Declaration
21st Oct 20217:00 amRNSNet Asset Value & Publication of Monthly Report
12th Oct 20216:00 pmRNSShort Form Amalgamation Announcement
22nd Sep 20217:00 amRNSNet Asset Value & Publication of Monthly Report
17th Sep 20217:00 amRNSInvestment in Marble Point CLO XXI
14th Sep 20217:00 amRNSDividend Declaration
13th Sep 20216:00 pmRNSSHORT FORM AMALGAMATION ANNOUNCEMENT
13th Sep 20216:00 pmRNSHalf-year Report
8th Sep 20216:00 pmRNSDirector/PDMR Shareholding
25th Aug 20217:00 amRNSNet Asset Value & Publication of Monthly Report
6th Aug 20217:00 amRNSPublication of Key Investor Document
5th Aug 20217:00 amRNSInvestment in Marble Point CLO XXII
21st Jul 20216:00 pmRNSSterling Dividend Amount
20th Jul 20217:00 amRNSNet Asset Value & Publication of Monthly report
1st Jul 20217:00 amRNSDividend Declaration
1st Jul 20217:00 amRNSB Share Voting Rights
28th Jun 20216:00 pmRNSDirector/PDMR Shareholding
28th Jun 20216:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSNet Asset Value & Publication of Monthly Report
14th Jun 20217:00 amRNSMP CLO VIII Reset Closing
1st Jun 20216:00 pmRNS1st Quarter Results
25th May 20217:00 amRNSInvestment in Marble Point CLO XX
24th May 20217:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Apr 20217:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Apr 20216:00 pmRNSSterling Dividend Amount
9th Apr 20216:00 pmRNSAnnual Financial Report
30th Mar 20217:00 amRNSDividend Declaration
24th Mar 20217:00 amRNSNet Asset Value & Publication of Monthly Report
26th Feb 20217:00 amRNSQ1 2021 Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.